Ohio hospital selects McKesson for IV automation

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

Riverside Methodist Hospital, part of OhioHealth, plans to implement the McKesson’s CytoCare robot for IV automation.

The new technology will enable Riverside Methodist Hospital, an 800-bed facility in Columbus, Ohio, to handle growth within its cancer services department, according to Atlanta-based McKesson.

CytoCare is designed to minimize clinical exposure to hazardous medications because it automates the compounding of hazardous IVs used for chemotherapy and monoclonal antibody therapy, the company added.